106 results on '"Murakami, S"'
Search Results
2. Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial
3. Prioritising low-risk and high-potential circular economy strategies for decarbonisation: A meta-analysis on consumer-oriented product-service systems
4. Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
5. Estimation of fuel particle balance in steady state operation with hydrogen barrier model
6. Strength of cylindrical butt joints bonded with epoxy adhesives under combined static or high-rate loading
7. Radiographic and pathological analysis of small lung adenocarcinoma using the new IASLC classification
8. 1789P Second OS interim analysis from BEAT-SC: A randomized phase III study of bevacizumab (bev) or placebo in combination with atezolizumab and platinum-based chemotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC)
9. 1243MO A phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin for concurrent chemoradiotherapy in elderly patients (≥75 years) with unresectable locally advanced NSCLC: JCOG1914
10. Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma
11. Effects of climate change on geo-disasters in coastal zones and their adaptation
12. The 2011 off the Pacific coast of Tohoku earthquake and response of high-rise buildings under long-period ground motions
13. Autoclaved spent substrate of hatakeshimeji mushroom ( Lyophyllum decastes Sing.) and its water extract protect cucumber from anthracnose
14. 1294P A final analysis of a phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non–small-cell lung cancer: TORG1937 (DATE study)
15. Extranuclear expression of hormone receptors in primary breast cancer
16. Effect of heat treatment on pseudoelasticity in Fe–25.0 at.% Al single crystals
17. Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma
18. 1186TiP EPONA, efficacy of osimertinib with platinum and pemetrexed in EGFR mutant non-small cell lung cancer patients bearing CNS metastasis, and have systemic progression but stable intracranial disease on OsimertiNib resistAnce (TORG 1938)
19. Turbulence characteristics of wind over a hill with a rough surface
20. Effects of aggression and wing removal on brain serotonin levels in male crickets, Gryllus bimaculatus
21. The Comparison of Postoperative Pain Between Umbilical and Suprapubic Incision in Laparoscopic Liver Resection
22. Asymptotic fields of stress and damage of a mode I creep crack in steady-state growth
23. CFD ANALYSIS OF TURBULENT FLOW PAST SQUARE CYLINDER USING DYNAMIC LES
24. 322P - Three-year overall survival update from the PACIFIC trial
25. 511P - Phase II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL study; TORG1424/OLCSG1402)
26. 1459PD - Efficacy of durvalumab in patients with stage III NSCLC who experience pneumonitis (PACIFIC)
27. LBA2 - Patient-reported outcomes (PROs) with durvalumab by PD-L1 expression in unresectable, stage III NSCLC (PACIFIC)
28. P001 - Consideration of optimal postoperative adjuvant therapy for HER2-positive, Stage I pT1N0 cases
29. 461P - Clinical courses of patients with small cell lung cancer after complete resection followed by adjuvant chemotherapy
30. 70O - Relationships between lenvatinib plasma concentration and toxicity in Japanese cancer patients
31. 535P - Association of immune-related pneumonitis with the phenotypic appearance of concurrent ILD in patients treated with anti-PD-1 antibody
32. 519P - Efficacy and safety of epidermal growth factor receptor (EGFR) - Tyrosine kinase inhibitors (TKI) in elderly patients with EGFR mutation-positive non-small cell lung cancer (NSCLC)
33. 1498P - Optimal interval from preceding radiotherapy (RT) to enhance efficacy of immune check point inhibitors (ICIs): Consecutive analysis of 294 patients with non-small cell lung cancer (NSCLC)
34. 1363O - Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC
35. 547P - Dried plasma spot assay for sunitinib and its active metabolite by high performance liquid chromatography tandem mass spectrometry
36. 438P - Efficacy of subsequent cytotoxic chemotherapy after nivolumab for patients with advanced non-small cell lung cancer
37. 403O - PACIFIC: A double-blind, placebo-controlled Phase III study of durvalumab as consolidation therapy after chemoradiation in patients with locally advanced, unresectable NSCLC
38. LBA1_PR - PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy (CRT) in patients with stage III, locally advanced, unresectable NSCLC
39. 460P Phase I/II trial of carboplatin, nab-paclitaxel and bevacizumab for advanced non-squamous non-small cell lung cancer (CARNAVAL; TORG1424/OLCSG1402): results of the phase I part
40. Spontaneous strain in high-temperature superconductor La 1.85Sr 0.15CuO 4
41. P225 Necessity of axillary lymph node dissection – future prospects in sentinel lymph-node positive cases
42. 1187P - Comparison of Malignant Grades Between Pure and Partially Invasive Types of Clinical Stage Ia Lung Adenocarcinoma
43. Oncocytic tumor in myoepithelioma arising from the grossopalatine gland
44. 185 ROLE OF C-TYPE NATRIURETIC PEPTIDE (CNP) IN OSTEOGENESIS AND TREATMENT OF OSTEOPOROSIS
45. An analysis of the prognostic significance of p53 status for squamous cell carcinoma of the oral cavity treated by radiotherapy
46. Identification of creep damage variable from [formula omitted] by a stochastic analysis
47. Acid-catalysed hydrolysis kinetics of carbonato cobalt(III) complexes with nonlabile tripodal quadridentate ligands
48. X-ray crystal structures of trans-(10-amino-3,7-diazadecanoato) dinitrocobalt(III) hydrate, mer( N)-(9-amino-3,7-diazanonato) dinitrocobalt(III) sesquihydrate, mer( N)-{ N-(2-aminoethyl- N-(3-aminopropyl)glycinato} dinitrocobalt(III) hydrate and mer-(1,6-diamino-3-azahexane) trinitrocobalt(III)
49. Observation of cosmic rays and auroral X-rays in the Polar Patrol Balloon experiment
50. Diagnostic imaging in two cases of recurrent maxillary ameloblastoma: comparative evaluation of plain radiographs, CT and MR images
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.